Generate Chart For |
|
|
(Chart displayed below) |
Rat Strains
{{sample.term}}
|
Measurement Methods
{{method.term}}
|
|
|
9 | left ventricular diastolic blood pressure | FHH-Chr 8BN/Mcwi | female | 44.1611 | mmHg | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 47702 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | |
9 | left ventricular diastolic blood pressure | FHH-Chr 8BN/Mcwi | male | 52.4333 | mmHg | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 47706 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | |
8 | left ventricular diastolic blood pressure | FHH-Chr 8BN/Mcwi | female | 45.17 | mmHg | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 46418 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
9 | left ventricular diastolic blood pressure | FHH-Chr 8BN/Mcwi | male | 34.13 | mmHg | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 46422 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
10 | arterial blood flow rate | FHH-Chr 8BN/Mcwi | male | 5.687 | ml/min/g | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 46206 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | |
9 | arterial blood flow rate | FHH-Chr 8BN/Mcwi | female | 6.5422 | ml/min/g | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 46202 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | |
10 | arterial blood flow rate | FHH-Chr 8BN/Mcwi | female | 6.699 | ml/min/g | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 44719 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
10 | arterial blood flow rate | FHH-Chr 8BN/Mcwi | male | 4.773 | ml/min/g | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 44723 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
2 | percent change in left ventricular developed pressure | FHH-Chr 8BN/Mcwi | female | 37.0975 | % | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 46320 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | |
6 | percent change in left ventricular developed pressure | FHH-Chr 8BN/Mcwi | male | 60.114 | % | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 46324 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | |
5 | percent change in left ventricular developed pressure | FHH-Chr 8BN/Mcwi | female | 35.7058 | % | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 48528 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
5 | percent change in left ventricular developed pressure | FHH-Chr 8BN/Mcwi | male | 44.3938 | % | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 48532 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
9 | percent change in heart rate | FHH-Chr 8BN/Mcwi | male | 102.1873 | % | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 48411 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | |
8 | percent change in heart rate | FHH-Chr 8BN/Mcwi | female | 106.215 | % | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 48407 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | |
7 | percent change in heart rate | FHH-Chr 8BN/Mcwi | female | 73.3433 | % | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 48296 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
9 | percent change in heart rate | FHH-Chr 8BN/Mcwi | male | 84.035 | % | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 48300 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
9 | left ventricular systolic blood pressure | FHH-Chr 8BN/Mcwi | female | 96.6511 | mmHg | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 44816 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | |
9 | left ventricular systolic blood pressure | FHH-Chr 8BN/Mcwi | male | 108.5911 | mmHg | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 44820 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | |
8 | left ventricular systolic blood pressure | FHH-Chr 8BN/Mcwi | female | 90.6938 | mmHg | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 49889 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
9 | left ventricular systolic blood pressure | FHH-Chr 8BN/Mcwi | male | 77.9111 | mmHg | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 49893 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
10 | heart left ventricle infarction weight to total heart left ventricle weight ratio | FHH-Chr 8BN/Mcwi | female | 9.583 | % | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) | 49397 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 3 hours) | |
10 | heart left ventricle infarction weight to total heart left ventricle weight ratio | FHH-Chr 8BN/Mcwi | male | 10.873 | % | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) | 49401 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 3 hours) | |
10 | heart left ventricle infarction weight to total heart left ventricle weight ratio | FHH-Chr 8BN/Mcwi | female | 1.828 | % | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) | 49699 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 3 hours) |
10 | heart left ventricle infarction weight to total heart left ventricle weight ratio | FHH-Chr 8BN/Mcwi | male | 7.381 | % | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) | 49703 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 3 hours) |
9 | time to peak heart contraction | FHH-Chr 8BN/Mcwi | male | 1152.6667 | s | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) | 46553 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | | |
9 | time to peak heart contraction | FHH-Chr 8BN/Mcwi | female | 1199.7778 | s | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) | 46549 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | | |
9 | time to peak heart contraction | FHH-Chr 8BN/Mcwi | male | 1155.2222 | s | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) | 50232 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | |
8 | time to peak heart contraction | FHH-Chr 8BN/Mcwi | female | 1172.5 | s | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) | 50228 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | |
9 | time to onset of heart contraction | FHH-Chr 8BN/Mcwi | female | 980 | s | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) | 50120 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | | |
9 | time to onset of heart contraction | FHH-Chr 8BN/Mcwi | male | 907.5556 | s | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) | 50124 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | | |
8 | time to onset of heart contraction | FHH-Chr 8BN/Mcwi | female | 902.75 | s | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) | 49300 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | |
9 | time to onset of heart contraction | FHH-Chr 8BN/Mcwi | male | 971.4444 | s | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) | 49304 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | |
6 | percent change in left ventricular systolic blood pressure | FHH-Chr 8BN/Mcwi | male | 106.7137 | % | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 44923 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | |
2 | percent change in left ventricular systolic blood pressure | FHH-Chr 8BN/Mcwi | female | 73.194 | % | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 44919 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | |
5 | percent change in left ventricular systolic blood pressure | FHH-Chr 8BN/Mcwi | female | 72.9376 | % | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 48757 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
5 | percent change in left ventricular systolic blood pressure | FHH-Chr 8BN/Mcwi | male | 76.332 | % | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 48761 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
9 | heart contraction pressure | FHH-Chr 8BN/Mcwi | female | 40.2222 | mmHg | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) | 48034 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | | |
9 | heart contraction pressure | FHH-Chr 8BN/Mcwi | male | 50 | mmHg | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) | 48038 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | | |
8 | heart contraction pressure | FHH-Chr 8BN/Mcwi | female | 34 | mmHg | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) | 49998 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | |
9 | heart contraction pressure | FHH-Chr 8BN/Mcwi | male | 29.6667 | mmHg | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) | 50002 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | |
9 | heart rate | FHH-Chr 8BN/Mcwi | female | 219.94 | beats/min | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 48946 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | |
9 | heart rate | FHH-Chr 8BN/Mcwi | male | 268.7822 | beats/min | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 48950 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | |
7 | heart rate | FHH-Chr 8BN/Mcwi | female | 182.8357 | beats/min | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 45149 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
9 | heart rate | FHH-Chr 8BN/Mcwi | male | 196.96 | beats/min | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 45153 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
9 | left ventricular developed pressure | FHH-Chr 8BN/Mcwi | female | 52.49 | mmHg | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 47912 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | |
9 | left ventricular developed pressure | FHH-Chr 8BN/Mcwi | male | 56.1578 | mmHg | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 47916 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | |
9 | left ventricular developed pressure | FHH-Chr 8BN/Mcwi | male | 43.7811 | mmHg | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 45275 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
8 | left ventricular developed pressure | FHH-Chr 8BN/Mcwi | female | 45.5238 | mmHg | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 45271 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
10 | percent change in arterial blood flow rate | FHH-Chr 8BN/Mcwi | male | 65.4855 | % | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 46071 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | |
9 | percent change in arterial blood flow rate | FHH-Chr 8BN/Mcwi | female | 83.3012 | % | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 46067 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | |
10 | percent change in arterial blood flow rate | FHH-Chr 8BN/Mcwi | female | 44.0071 | % | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 47078 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
10 | percent change in arterial blood flow rate | FHH-Chr 8BN/Mcwi | male | 37.145 | % | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) | 47082 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
10 | heart effluent lactate dehydrogenase activity level normalized to heart weight | FHH-Chr 8BN/Mcwi | female | 25.7507 | IU/g | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) | 48868 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 1.5 hours) | |
10 | heart effluent lactate dehydrogenase activity level normalized to heart weight | FHH-Chr 8BN/Mcwi | male | 27.4697 | IU/g | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) | 48879 | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 1.5 hours) | |
10 | heart effluent lactate dehydrogenase activity level normalized to heart weight | FHH-Chr 8BN/Mcwi | female | 22.8159 | IU/g | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) | 45974 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
10 | heart effluent lactate dehydrogenase activity level normalized to heart weight | FHH-Chr 8BN/Mcwi | male | 22.8014 | IU/g | air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) | 45982 | air oxygen content (12 %) (for 14 days) | controlled oxygen content Kreb's solution perfusate (for 0.5 hours) | perfusate suspended (for 0.4 hours) | controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |